NO993151L - Fremgangsmåte for fremstilling av renset dimer av benavledet faktor - Google Patents

Fremgangsmåte for fremstilling av renset dimer av benavledet faktor

Info

Publication number
NO993151L
NO993151L NO993151A NO993151A NO993151L NO 993151 L NO993151 L NO 993151L NO 993151 A NO993151 A NO 993151A NO 993151 A NO993151 A NO 993151A NO 993151 L NO993151 L NO 993151L
Authority
NO
Norway
Prior art keywords
dimer
derived factor
subjecting
bone
preparation
Prior art date
Application number
NO993151A
Other languages
English (en)
Other versions
NO993151D0 (no
Inventor
Hidetoshi Andou
Jun Honda
Shunjiro Sugimoto
Original Assignee
Hoechst Marion Roussel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18445882&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO993151(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoechst Marion Roussel Ltd filed Critical Hoechst Marion Roussel Ltd
Publication of NO993151L publication Critical patent/NO993151L/no
Publication of NO993151D0 publication Critical patent/NO993151D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Fremgangsmåte for fremstilling av en renset dimer av en benavledet faktor, som omfatter underkastelse av et inklusjonslegeme av en benavledet faktor fremstilt ved hjelp av genetisk konstruksjon for følgende trinn a) til. e) i rekkefølge; a) trinnet med behandling av et inklusjonslegeme av en benavledet faktor med et denaturerende middel for å fremstille en oppløst monomer; b) trinnet med behandling av den oppløste monomer med en refoldende oppløsning for å fremstille en dimer; c) trinnet med underkastelse av den refoldende dimer for ultrafiltrering og utbytting av oppløsningsmiddel; d) trinnet med underkastelse av dimeroppløsningen fremstilt ovenfor for isoelektrisk utfelling; og e) trinnet med underkastelse av den isoelektrisk utfelte dimer for revers-fasekromatografi.
NO993151A 1996-12-25 1999-06-24 FremgangsmÕte for fremstilling av renset dimer av benavledet faktor NO993151D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP35581296 1996-12-25
PCT/JP1997/004784 WO1998029559A1 (fr) 1996-12-25 1997-12-24 Procede de preparation de dimeres purifies a partir de facteur derive de l'os

Publications (2)

Publication Number Publication Date
NO993151L true NO993151L (no) 1999-06-24
NO993151D0 NO993151D0 (no) 1999-06-24

Family

ID=18445882

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993151A NO993151D0 (no) 1996-12-25 1999-06-24 FremgangsmÕte for fremstilling av renset dimer av benavledet faktor

Country Status (21)

Country Link
US (1) US6551801B1 (no)
EP (1) EP0949335B2 (no)
KR (1) KR20000062328A (no)
AP (1) AP9901539A0 (no)
AT (1) ATE266095T1 (no)
AU (1) AU5339598A (no)
BR (1) BR9714183A (no)
CA (1) CA2275464A1 (no)
DE (1) DE69728997T3 (no)
DK (1) DK0949335T4 (no)
EA (1) EA199900596A1 (no)
ES (1) ES2216181T5 (no)
HU (1) HUP0002573A2 (no)
IL (1) IL130641A0 (no)
NO (1) NO993151D0 (no)
PL (1) PL334303A1 (no)
PT (1) PT949335E (no)
SI (1) SI0949335T2 (no)
TR (1) TR199901479T2 (no)
WO (1) WO1998029559A1 (no)
ZA (1) ZA9711580B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040019185A1 (en) * 1996-12-25 2004-01-29 Hidetoshi Andou Process for preparing purified active monomer of bone-derived factor
US7811793B2 (en) * 1996-12-25 2010-10-12 Biopharma Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Process for preparing purified active monomer of bone-derived factor
US20030120042A1 (en) * 2000-03-30 2003-06-26 Takao Yamada Process for producing recombinant protein
CA2474919A1 (en) * 2002-02-08 2003-08-14 Wyeth Formulation comprising bioactive agents and method of using same
JP2006508049A (ja) * 2002-08-13 2006-03-09 ワイエス 増殖因子βタンパク質を形質転換するための可溶化賦形剤としてのペプチド
JP4800739B2 (ja) * 2005-10-20 2011-10-26 デンカ生研株式会社 アッセイ用媒体及びアッセイ方法
AR062711A1 (es) * 2006-09-08 2008-11-26 Wyeth Corp Lavado de arginina en l a purificacion de proteinas usando cromatografia de afinidad
AU2007234612B2 (en) * 2006-12-14 2013-06-27 Johnson & Johnson Regenerative Therapeutics, Llc Protein stabilization formulations
US7678764B2 (en) 2007-06-29 2010-03-16 Johnson & Johnson Regenerative Therapeutics, Llc Protein formulations for use at elevated temperatures
WO2009020744A1 (en) 2007-08-07 2009-02-12 Johnson & Johnson Regenerative Therapeutics, Llc Protein formulations comprising gdf-5 in aqueous acidic solution
BRPI0911048A2 (pt) * 2008-04-14 2015-12-29 Atrm Llc formulações líquidas tamponadas de gdf-5
US8455436B2 (en) 2010-12-28 2013-06-04 Depuy Mitek, Llc Compositions and methods for treating joints
US8398611B2 (en) 2010-12-28 2013-03-19 Depuy Mitek, Inc. Compositions and methods for treating joints
US8524662B2 (en) 2010-12-28 2013-09-03 Depuy Mitek, Llc Compositions and methods for treating joints
US8623839B2 (en) 2011-06-30 2014-01-07 Depuy Mitek, Llc Compositions and methods for stabilized polysaccharide formulations
US9682099B2 (en) 2015-01-20 2017-06-20 DePuy Synthes Products, Inc. Compositions and methods for treating joints

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68929472T2 (de) * 1988-04-08 2004-05-13 Stryker Corp., Kalamazoo Biosynthetische knochenbildende Proteine, und sie enthaltende knochenbildende Vorrichtungen
AU678380B2 (en) * 1992-07-31 1997-05-29 Stryker Corporation Morphogenic protein soluble complex and composition thereof
JP3570558B2 (ja) * 1993-05-01 2004-09-29 持田製薬株式会社 Ｄｎａ断片およびそれを含むベクター、該ベクターによって形質転換された形質転換体、該ベクターを用いる蛋白質の産生方法
US5385887A (en) * 1993-09-10 1995-01-31 Genetics Institute, Inc. Formulations for delivery of osteogenic proteins
US5399677A (en) * 1993-12-07 1995-03-21 Genetics Institute, Inc. Mutants of bone morphogenetic proteins
US5702637A (en) * 1995-04-19 1997-12-30 Minnesota Mining And Manufacturing Company Liquid crystal compounds having a chiral fluorinated terminal portion
US7235527B2 (en) * 1995-04-19 2007-06-26 Biopharm Gesellschaft Zur Biotechnologieschen Entwicklung Von Pharmaka Mbh Protein and process for producing the same

Also Published As

Publication number Publication date
SI0949335T1 (en) 2004-10-31
TR199901479T2 (xx) 1999-09-21
EA199900596A1 (ru) 2000-02-28
US6551801B1 (en) 2003-04-22
CA2275464A1 (en) 1998-07-09
DE69728997D1 (de) 2004-06-09
EP0949335B2 (en) 2008-11-19
ES2216181T5 (es) 2009-03-01
WO1998029559A1 (fr) 1998-07-09
SI0949335T2 (sl) 2009-04-30
AU5339598A (en) 1998-07-31
HUP0002573A2 (hu) 2000-12-28
EP0949335B1 (en) 2004-05-06
IL130641A0 (en) 2000-06-01
PT949335E (pt) 2004-09-30
ATE266095T1 (de) 2004-05-15
NO993151D0 (no) 1999-06-24
BR9714183A (pt) 2000-02-29
DE69728997T2 (de) 2004-09-02
EP0949335A4 (en) 2003-01-22
EP0949335A1 (en) 1999-10-13
DK0949335T3 (da) 2004-08-30
DK0949335T4 (da) 2009-03-23
PL334303A1 (en) 2000-02-14
AP9901539A0 (en) 1999-06-30
DE69728997T3 (de) 2009-07-09
ES2216181T3 (es) 2004-10-16
ZA9711580B (en) 1999-09-23
KR20000062328A (ko) 2000-10-25

Similar Documents

Publication Publication Date Title
PT83205B (pt) Metodo de purificacao e activacao de proteinas a partir de corpos de inclusao insoluveis
ATE192486T1 (de) Chondroitinase, herstellungsverfahren und pharmazeutische zusammensetzung
DK0775150T3 (da) Fremgangsmåde til reduktion eller fjernelse af endotoksiner
ATE169030T1 (de) Fusionsproteine mit immunglobulinanteilen, ihre herstellung und verwendung
ATE403671T1 (de) Methoden zur aufreinigung von rekombinatem humanem erythropoietin aus zellkulturüberständen
AP9901539A0 (en) Process for preparing purified dimer of bone-derived.
NO912418L (no) Fremgangsmaate for behandling av blaerecancerceller
KR930010177A (ko) 하이브리드 형질전환 성장인자
DE59706780D1 (de) Verfahren zur herstellung von solvens-stabilisierten metallkolloiden und trägerfixierten metallclustern
DK573587A (da) Fremgangsmaade til fremstilling af en faktor viii (ahf)-holdig fraktion
KR960009052B1 (en) Simultaneous preparation process of useful proteins from human urine
NZ333712A (en) Method of refolding proteins using a dithiol compound a catalyst and a test to determine the potential use of compounds as protein refolding catalyst
KR910000176A (ko) 맥관 형성 저해제
ATE341943T1 (de) Verfahren zur extraktion, reinigung und enzymatischen veränderung von soja 7s globulin alpha' untereinheit zur verwendung als hypocholesterol-mischer-wirkstoff
DE3878577D1 (de) Verwendung von funktionellen polymerharzen als stationaere phase in der affinitaetschromatographie fuer die reinigung des wachstumsfaktors und entsprechendes reinigungsverfahren.
DE69521887D1 (de) Verbessertes verfahren zur herstellung von 6,9[(zaminoethyl)amino]benzo[g]isochinoline-5,10 dione und sein dimaleinsaeure salz
ATE294807T1 (de) Kugelförmige molekülgruppierung
ATE323760T1 (de) Verfahren zur herstellung eines eine hyaluronidase enthaltenden präparats
Judy et al. Photochemical cross-linking of type I collagen with hydrophobic and hydrophilic 1, 8-naphthalimide dyes
RU96124332A (ru) Ареактогенный иммуноглобулин для внутривенного введения и способ его получения
AU3823195A (en) Process for recovering citric acid
AU3053884A (en) Heterogeneous oligosaccharides
YU28799A (en) Process for preparing purified dimer of bone-derived factor
SU763361A1 (ru) Способ регулировани процесса очистки от примесей возвратного растворител
KR960031596A (ko) 신규의 혈전용해효소 및 이의 정제 방법

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application